透明细胞肾细胞癌中OVO样蛋白的表达、预后价值及生物学重要性的综合分析

Comprehensive analysis of the expression, prognostic value and biological importance of OVO‑like proteins in clear cell renal cell carcinoma.

作者信息

Lin Jinfang, Jiang Ming, Chen Ru, Zheng Ping, Chen Guoxian

机构信息

Department of Urology, The First Hospital of Putian City, Putian, Fujian 351100, P.R. China.

Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

出版信息

Oncol Lett. 2023 Mar 17;25(5):179. doi: 10.3892/ol.2023.13765. eCollection 2023 May.

Abstract

This study examined the expression levels of OVO-like proteins (OVOLs) in clear cell renal cell carcinoma (ccRCC) tissues and their value in predicting disease prognosis. The transcript levels, genetic alterations, and biological functions of OVOLs and their correlation with tumor immune cell infiltration and drug sensitivity and survival outcomes, as well as their prognostic values, in patients with ccRCC were analyzed based on data obtained from The Cancer Genome Atlas, Gene Expression Profiling Interactive Analysis, cBioPortal, and GSCALite databases. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed using R software (Bioconductor, clusterProfiler packages). A protein-protein interaction network was established and visualized using the R software with the ggplots package. The ggstatsplot package was used to plot the correlation between gene expression and immune cell infiltration. The mRNA expression levels of and were significantly downregulated in patients with ccRCC, whereas those of were upregulated. expression was correlated with tumor stage and histological grades. The , and levels were significantly correlated with the prognosis of patients with ccRCC, the infiltration of immune cells, and drug sensitivity. Multivariate and univariate analyses showed that the expression of was an independent prognostic factor for the overall survival (OS) of patients with ccRCC. The OVOL proteins were associated with various pathways, including tight junction, cell adhesion molecules, and ether lipid metabolism. Additionally, upregulation, and and downregulation in clinical ccRCC samples were experimentally verified. Thus, OVOL1 and OVOL2 are potential therapeutic targets and prognostic markers for ccRCC. Additionally, OVOL1 can serve as an independent prognostic factor for OS in patients with ccRCC.

摘要

本研究检测了透明细胞肾细胞癌(ccRCC)组织中OVO样蛋白(OVOLs)的表达水平及其在预测疾病预后中的价值。基于从癌症基因组图谱(The Cancer Genome Atlas)、基因表达谱交互分析(Gene Expression Profiling Interactive Analysis)、cBioPortal和GSCALite数据库获得的数据,分析了ccRCC患者中OVOLs的转录水平、基因改变、生物学功能及其与肿瘤免疫细胞浸润、药物敏感性和生存结果的相关性,以及它们的预后价值。使用R软件(Bioconductor,clusterProfiler包)进行基因本体论(Gene Ontology)和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes)分析。使用R软件和ggplots包建立并可视化蛋白质-蛋白质相互作用网络。使用ggstatsplot包绘制基因表达与免疫细胞浸润之间的相关性。ccRCC患者中[具体基因1]和[具体基因2]的mRNA表达水平显著下调,而[具体基因3]的表达上调。[具体基因4]表达与肿瘤分期和组织学分级相关。[具体基因5]、[具体基因6]和[具体基因7]水平与ccRCC患者的预后、免疫细胞浸润和药物敏感性显著相关。多因素和单因素分析表明,[具体基因8]的表达是ccRCC患者总生存期(OS)的独立预后因素。OVOL蛋白与多种途径相关,包括紧密连接、细胞粘附分子和醚脂代谢。此外,临床ccRCC样本中[具体基因A]上调以及[具体基因B]和[具体基因C]下调通过实验得到验证。因此,OVOL1和OVOL2是ccRCC潜在的治疗靶点和预后标志物。此外,OVOL1可作为ccRCC患者OS的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9985/10079820/770636786925/ol-25-05-13765-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索